BIOMARIN PHARMACEUTICAL INC Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for February 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 22 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 7,000 | 185,430 | 92,513 | |
| Feb 22 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 83.58 | 7,000 | 585,060 | 295,552 | 302.6 K to 295.6 K (-2.31 %) |
| Feb 22 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 7,000 | 185,430 | 302,552 | 295.6 K to 302.6 K (+2.37 %) |
| Feb 19 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 7,000 | 185,430 | 99,513 | |
| Feb 19 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 85.08 | 7,000 | 595,560 | 295,552 | 302.6 K to 295.6 K (-2.31 %) |
| Feb 19 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 7,000 | 185,430 | 302,552 | 295.6 K to 302.6 K (+2.37 %) |
| Feb 19 2021 | BMRN | BIOMARIN PHARMACEU ... | Ho Maykin | Director | Grant | A | 0.00 | 2,350 | 0 | 2,350 | 0 to 2.4 K |
| Feb 18 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 8,000 | 211,920 | 106,513 | |
| Feb 18 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 84.54 | 8,000 | 676,320 | 295,552 | 303.6 K to 295.6 K (-2.64 %) |
| Feb 18 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 8,000 | 211,920 | 303,552 | 295.6 K to 303.6 K (+2.71 %) |
| Feb 04 2021 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | EVP, Chief Financia ... | Payment of Exercise | F | 82.82 | 1,071 | 88,700 | 28,673 | 29.7 K to 28.7 K (-3.60 %) |
| Feb 01 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 8,334 | 220,768 | 114,513 | |
| Feb 01 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 8,333 | 220,741 | 122,847 | |
| Feb 01 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.67 | 8,334 | 688,972 | 295,552 | 303.9 K to 295.6 K (-2.74 %) |
| Feb 01 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 8,334 | 220,768 | 303,886 | 295.6 K to 303.9 K (+2.82 %) |
| Feb 01 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.91 | 8,333 | 690,889 | 295,552 | 303.9 K to 295.6 K (-2.74 %) |
| Feb 01 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 8,333 | 220,741 | 303,885 | 295.6 K to 303.9 K (+2.82 %) |